SightfileU.S. market data from official filings

Companies › MENS

JYONG BIOTECH LTD (MENS)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001954488 · EDGAR filings · Updated 2026-05-15

JYONG BIOTECH LTD (MENS) has reported institutional ownership of 0.6%, with 17 institutional managers holding positions valued at $974.0K per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
0.6%
Institutional managers
17
Reported 13F value
$974.0K
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, JYONG BIOTECH LTD has 17 institutional holders and institutional ownership of 0.6%.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-15 (recurring since 2026-05-15) — source filing. The authoritative details are those stated in the filing itself.

Related companies

ENVVENO MEDICAL CORPORATION (NVNO) · BioNano Genomics Inc (BNGO) · Icecure Medical Ltd (ICCM) · Beyond Air Inc (XAIR) · SEASTAR MEDICAL HOLDING CORP (ICU) · BIOAFFINITY TECHNOLOGIES INC (BIAF)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-05-15.